Do you have a technology that has progressed beyond basic research and has demonstrated proof-of-concept? Does the project require a health economic study or clinical trial or clinical utility study? Do you have a technology outside of the healthcare sphere that you believe has medical application?
The i4i Product Development awards support research and development of medical devices, active implantable devices and in vitro diagnostic devices in any area of existing or emerging clinical need. These awards comprise both early and late stages of research and development, including the clinical development of laboratory-validated technologies or interventions.
The call opens on April 6th 2016 with an application deadline of 1st June 2016. There is no upper limit on project costs if appropriately justified.
With over 25 years of experience supporting companies to develop and launch medical devices, Medilink is ideally positioned to partner with you to help deliver on your product R&D objectives.
Listed below are the acceptable activities allowed within this award:
Research and development of medical devices, active implantable devices and in vitro diagnostic devices as defined by the relevant EU directives, across all areas of existing or emerging healthcare need (for examples see http://www.nihr.ac.uk/research/invention-for-innovation_1.htm)
Research and development of technologies or interventions as defined by the current Challenge awards themes including Trauma and Critical Care & Oncology Diagnostics.
Product development required to enable a technology for clinical use; work packages may comprise all aspects around manufacturing, intellectual property protection, freedom to operate analysis and market analysis, business case development, etc
Research and development of techniques or technologies from a different industry sector, which could have a potential impact if applied in a healthcare setting
Feasibility studies if a technology from a sector other than health is being developed
Studies to provide data relating to safety and effectiveness of a device, including first-in-man and pivotal studies
Health economic analyses and clinical utility studies, looking at a device’s real-life implementation and use
CE marking and other regulatory requirements, including any associated safety trials
Activities associated with the adoption of new technology
Training associated with the implementation of new technology
Medilink are actively seeking companies suitable for collaborative bids, for more information on how Medilink can assist, please contact the Medilink Innovation team on 0161 477 7785 or email Jamie.email@example.com